# The Incommensurability Principle in Biological Transport

Preprint · Riccardo Marchesi

- Archive id: arxiv:2605.03219
- Published: 2026-05-04
- arXiv: https://arxiv.org/abs/2605.03219
- Citations: 0
- Source URL: https://arxiv.org/abs/2605.03219
- PDF: https://arxiv.org/pdf/2605.03219
- Provenance: arxiv

## Abstract

Why does the mammalian vascular tree maintain a conserved branching exponent $α^\* \\approx 2.72$ across a $10^7$-fold range in body mass, despite a fundamental shift from viscous to wave-dominated transport? We prove this universality cannot emerge from local optimization: any junction-level coupling of incommensurable costs requires scale-dependent fine-tuning varying by $O(10^2$--$10^3)$ across the hierarchy. Real networks resolve this through structural heterogeneity, and vascular geometry emerges as a scale-free attractor of a network-level minimax principle. Grounding the fitness penalty in ATP stoichiometry, we prove a Topological Rigidity theorem: the optimal branching exponent depends only on dimensionless structural parameters $(G, N, p, α\_w)$, independent of all metabolic quantities. A self-consistency condition on the viscous--inertial energy partition yields a dual-threshold framework with $\\mathrm{Wo}\_c^{\\mathrm{fluid}} = \\sqrt{3}$ and $\\mathrm{Wo}\_c^{\\mathrm{wave}} = 3/\\sqrt{2}$. The symmetric model yields $α^\*\_{\\mathrm{model}} \\approx 2.626$, in agreement with mammals near the allometric transition; morphometric heterogeneities shift large-mammal values toward $2.72$. The framework explains developmental stability of cardiovascular networks as a consequence of architecture being decoupled from biochemistry.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Cardiovascular Therapeutics](https://space-kitty.com/topics/cardiovascular-innovation)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.